-+ 0.00%
-+ 0.00%
-+ 0.00%

BAUSCH HEALTH CANADA ANNOUNCES EXPANDED PUBLIC REIMBURSEMENT FOR (PR)OKEDI® (RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION) ACROSS CANADA FOR THE TREATMENT OF SCHIZOPHRENIA

Reuters·10/19/2026 12:00:22

Please log in to view news